XML 36 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The income tax provision consists of the following (in thousands):
 
 
For the Years Ended
December 31,
 
 
2015
 
2014
 
2013
Current provision:
 
 
 
 
 
 
Federal
 
$

 
$

 
$

State
 
30

 
21

 
(70
)
Foreign
 
1,772

 
2,127

 
2,299

Total current provision
 
1,802

 
2,148

 
2,229

Deferred provision (benefit):
 
 
 
 
 
 
Federal
 
35

 
(73
)
 

State
 
2

 
(3
)
 

Foreign
 
(97
)
 
420

 
12,726

Total deferred provision
 
(60
)
 
344

 
12,726

Total income tax provision
 
$
1,742

 
$
2,492

 
$
14,955


The income tax provision (benefit) differs from the amount computed by applying the statutory federal income tax rate to pretax income as a result of the following differences (dollar amounts in thousands):
 
 
For the Years Ended December 31,
 
 
2015
 
2014
 
2013
 
 
$
 
%
 
$
 
%
 
$
 
%
Statutory federal tax (benefit) rate
 
$
(4,526
)
 
35.0
 %
 
$
(8,781
)
 
35.0
 %
 
$
(12,057
)
 
35.0
 %
Increase (decrease) in rates resulting from:
 
 
 
 
 
 
 
 
 
 
 
 
State taxes
 
609

 
(4.7
)
 
(246
)
 
1.0

 
(356
)
 
1.0

Foreign dividends and unremitted earnings
 
1,493

 
(11.5
)
 
(586
)
 
2.3

 
1,938

 
(5.6
)
Valuation allowance
 
2,456

 
(18.6
)
 
7,367

 
(29.4
)
 
26,662

 
(77.4
)
Taxes on foreign income that differ from U.S. tax rate
 
(405
)
 
3.1

 
2,488

 
(9.9
)
 
(2,314
)
 
6.7

Tax credits
 
433

 
(3.3
)
 

 

 
(252
)
 
0.7

Non-deductible stock-based compensation expense
 
1,104

 
(8.5
)
 
1,206

 
(4.8
)
 
1,596

 
(4.6
)
Earnout liability fair value adjustment
 
(2
)
 

 
(43
)
 
0.2

 
(596
)
 
1.7

Uncertain tax positions
 
435

 
(3.4
)
 
362

 
(1.4
)
 
530

 
(1.5
)
Other
 
145

 
(1.6
)
 
725

 
(2.9
)
 
(196
)
 
0.6

Effective tax rate
 
$
1,742

 
(13.5
)%
 
$
2,492

 
(9.9
)%
 
$
14,955

 
(43.4
)%

The components of deferred taxes consist of the following (in thousands):
 
 
December 31,
2015
 
December 31,
2014
Deferred tax assets:
 
 
 
 
Accrued warranty
 
$
919

 
$
937

Inventory
 
2,697

 
1,731

Restructuring accrual
 
5

 
58

Net operating loss carryforwards
 
59,784

 
61,521

Tax credit carryforwards
 
22,817

 
23,866

Stock-based compensation
 
2,142

 
2,042

Fixed assets
 
952

 
950

Goodwill
 
2,109

 
2,516

Other
 
5,693

 
4,056

Total deferred tax assets
 
97,118

 
97,677

Less: valuation allowance
 
(86,752
)
 
(84,240
)
Net deferred tax assets
 
10,366

 
13,437

Deferred tax liabilities:
 
 
 
 
Intangible assets
 
(7,582
)
 
(11,764
)
Other
 
(1,611
)
 
(593
)
Total deferred tax liabilities
 
(9,193
)
 
(12,357
)
Total net deferred tax assets
 
$
1,173

 
$
1,080



At December 31, 2015, the Company's unrecognized tax benefits associated with uncertain tax positions were $3.7 million, of which $3.3 million, if recognized, would favorably affect the effective tax rate.

The Company's ongoing practice is to recognize potential accrued interest and penalties related to unrecognized tax benefits within its global operations in income tax expense. During 2015, the Company recognized a net increase of approximately $0.1 million in potential interest and penalties associated with uncertain tax positions in the Consolidated Statements of Operations. The Company had approximately $0.6 million and $0.3 million of interest and penalties associated with uncertain tax positions at December 31, 2015, which are excluded from the unrecognized tax benefits table below.

The Company’s total amounts of unrecognized tax benefits at the beginning and end of the period are as follows (in thousands):
 
Total
Balance as of December 31, 2013
$
3,446

Additions based on tax positions related to the current year
357

Additions for tax positions of prior years
76

Reductions for tax positions of prior years
(98
)
Reductions as a result of a lapse of applicable statute of limitations
(95
)
Other
2

Balance as of December 31, 2014
$
3,688

Additions based on tax positions related to the current year
329

Additions for tax positions of prior years
67

Reductions for tax positions of prior years
(204
)
Reductions as a result of a lapse of applicable statute of limitations
(70
)
Reductions due to settlements
(28
)
Other
(102
)
Balance as of December 31, 2015
$
3,680



The Company and its subsidiaries are subject to federal income tax as well as income tax of multiple state and foreign jurisdictions. The Company's statutes of limitations are closed for all federal and state income tax years before 2012 and 2011. The statutes of limitations for the Company's other foreign subsidiaries are closed for all income tax years before 2006. However, to the extent allowed by law, the taxing authorities may have the right to examine prior periods where net operating losses and credits were generated and carried forward, and make adjustments up to the net operating loss and credit carryforward amounts. It is reasonably possible that the Company's uncertain tax positions, including interest and penalties, could decrease by approximately $0.4 million in the next twelve months.

The Company is currently under examination in India. The periods covered by the examination are the Company's financial years 2005, 2006 and 2010. The examination is in various stages of appellate proceedings and all material uncertain tax positions associated with the examination have been taken into account in the ending balance of the unrecognized tax benefits at December 31, 2015.

The Company has recorded valuation allowances of $86.8 million and $84.2 million as of December 31, 2015 and 2014. This represents a full valuation allowance against the Company's U.S., Korean, Malaysian and Japanese net deferred tax assets as well as a partial valuation allowance against the Company's Canadian net deferred tax assets. During 2015, the Company established a valuation allowance against the net deferred tax assets of Korea, Malaysia and Japan as the Company will no longer maintain operations in those jurisdictions. During 2013, the Company recognized the partial valuation allowance against the Company's Canadian net deferred tax assets due to expected changes in the nature of the Company's operations in Canada. In evaluating its valuation allowance, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance.

At December 31, 2015 the Company had total available federal and state net operating loss carryforwards of approximately $167.1 million and $79.7 million. The federal and state net operating loss carryforwards expire between 2017 and 2034. The net operating losses from acquisitions are stated net of limitations pursuant to Section 382 of the Internal Revenue Code. The Company also had net operating loss carryforwards of approximately $5.7 million from the United Kingdom (“U.K.”), Malaysia, Korea and China. The U.K. and Malaysian net operating losses may be carried forward indefinitely provided certain requirements are met. The Chinese and Korean tax losses may be carried forward 5 and 10 years, respectively.

The Company has federal and state research and development tax credit and other federal credit carryforwards of approximately $16.2 million at December 31, 2015, to reduce future income tax liabilities.  The federal and Oregon credits expire between 2016 and 2031.  The California research and development credits do not expire.  The credits from acquisitions are stated net of limitations pursuant to Section 383 of the Internal Revenue Code.  The Company's Canadian subsidiary also had approximately $4.6 million in investment tax credit, $16.0 million of unclaimed scientific research and experimental expenditures to be carried forward and applied against future income in Canada.

Realization of the Company's foreign deferred tax assets is dependent on generating sufficient taxable income prior to the expiration of the net operating loss and tax credit carryforwards. Although realization is not assured, management believes that it is more likely than not that the results of future operations will generate sufficient taxable income to realize the balance of the deferred tax assets, net of the valuation allowance, as of December 31, 2015. The amount of the net deferred tax assets that is considered realizable, however, could be reduced if estimates of future taxable income during the carryforward periods are reduced. Should management determine that the Company would not be able to realize all or part of the net deferred tax assets in the future, adjustments to the valuation allowance for deferred tax assets may be required.

The company has provided a deferred tax liability of $1.3 million related to $3.8 million of unremitted earnings of certain foreign subsidiaries. The Company plans to indefinitely reinvest the earnings of certain foreign subsidiaries. Should the Company repatriate any foreign earnings from the remaining subsidiaries in the future, it may be required to establish an income tax liability and recognize additional income tax expense related to such earnings. The Company has indefinitely reinvested approximately $10.9 million of the undistributed earnings from the foreign subsidiaries at December 31, 2015. Such earnings would be subject to U.S. taxation if repatriated to the U.S.

Pretax book loss from domestic operations for the fiscal years 2015, 2014, and 2013 was $15.8 million, $29.9 million, and $47.2 million. Pretax book income from foreign operations for the fiscal years 2015, 2014, and 2013 was $2.9 million, $4.8 million, and $12.8 million.